Physicians’ Education Resource® to Present Five CE-Certified Satellite Symposia at the 44th ONS Annual Congress

“We look forward to presenting our five educational activities to the attendees at this year’s 44th ONS Annual Congress,” said Phil Talamo, president of PER®. “These programs will cover a wide range of topics in cancer to help oncology nurses provide better patient care from the frontlines.”

The PER^® satellite symposia slated for the ONS annual conference are:

• Onco-Nurse Academy™: 101 on CAR T-Cell Therapies, which will be held as a dinner symposium on Thursday, April 10, from 6 to 7:30 p.m. in the Marriott Marquis Center Ballroom. The program will be chaired by Cameron Turtle, MBBS, Ph.D., FRACP, FRCPA, associate professor at University of Washington School of Medicine and associate member of the clinical research division at Fred Hutchinson Cancer Research Center. During this program, the expert faculty will provide information on the role of CAR T-cell therapy in treating patients with hematologic malignancies as well as review the recent and ongoing clinical trials evaluating the future role of CAR T-cell therapy. Additionally, the faculty will discuss common and serious adverse events associated with CAR T-cell therapy and how to manage these side effects. To register, click here.
• Nursing Essentials: Optimized Care Strategies for the Patient With Advanced Renal Cell Carcinoma, which will be held as a desert symposium on Thursday, April 10, from 8 to 9:30 p.m. in the Platinum Ballroom 1-3. The program will be co-chaired by Robert A. Figlin, M.D., FACP, Steven Spielberg Family Chair in Hematology-Oncology, the director of the division of hematology/oncology, the deputy director of integrated oncology service line and a professor of medicine and biomedical sciences at Cedars-Sinai Medical Center, and Laura S. Wood, M.S.N, RN, OCN, renal cancer research coordinator at Cleveland Clinic Taussig Cancer Center. During this program, the expert faculty will provide attendees with a knowledge of the biology underpinning new therapies, clinical data leading to approvals, and how to mitigate and manage adverse events associated with targeted therapies and immunotherapy. An extended, case-based discussion will also illustrate how to apply new standards of care to their practice. To register, click here.
• Working Group to Optimize Outcomes in Myelofibrosis and Polycythemia Vera: Real-World Applications for Nurses, which will be held as a breakfast symposium on Friday, April 12, from 6 to 7:30 a.m. in the Marriott Grand Ballroom E-K. The program will be co-chaired by Daniel J. DeAngelo, M.D., Ph.D., professor of medicine at Harvard Medical School, and chief of the division of leukemia at Dana-Farber Cancer Institute, and Ilene Galinsky, M.S.N., B.S.N., ANP-C, senior program research nurse practitioner at Dana-Farber Cancer Institute. During this program, the expert faculty will update oncology nurses on recent developments in the management of patients with myeloproliferative neoplasms including myelofibrosis and polycythemia vera, as well as explain the key role that oncology nurses play in coordinating the multidisciplinary care team to manage treatment-related adverse events and maximize treatment adherence. To register, click here.
• Optimizing Outcomes in Melanoma with BRAF/MEK Inhibitor and Immunotherapeutic Strategies: Essentials for the Onco-Nurse, which will be held on as a dinner symposium on Friday, April 12, from 6 to 7:30 p.m. in the Marriott Grand Ballroom E-K. The program will be chaired by Omid Hamid, M.D., chief of translational research and immunotherapy and director of melanoma therapeutics at The Angeles Clinic and Research Institute. During this program, the expert faculty will discuss the latest trends in the treatment of patients with advanced-stage melanoma using treatments such as immune checkpoint inhibitors and BRAF/MEK inhibitors. This program will encourage better communication and effective multidisciplinary care to optimize outcomes for your patients with melanoma. To register, click here.
• Recognizing and Treating Oncologic Emergencies in the Cancer Patient: What Does the Nurse Need to Know? which will be held as a desert symposium on Friday, April 12, 8 to 9:30 p.m. in the Platinum Ballroom 1-3. The program will be chaired by Beth Fairman, Ph.D., CNP, adult nurse practitioner in the department of hematologic oncology and blood disorders at Cleveland Clinic Taussig Cancer Center. During this program, the expert faculty will highlight best practices in identifying patients at risk of oncologic emergencies, strategies to recognize and treat associated symptoms, and applications of nursing management strategies across a continuum of care. To register, click here.

Accredited by the Accreditation Council for Continuing Medical Education (ACCME) and approved by California Board of Registered Nursing, each PER session provides attendees with the opportunity to earn up to 1.5 AMA PRA Category 1 Credits™ and nursing contact hours.

About Physicians’ Education Resource^® (PER^®)

Since 1995, PER^® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER^® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside of oncology, PER^® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER^® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER^® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190401005586/en/